IPOGrid
0002086716
IPO filing research

Standard Nuclear, Inc.

Industrial Inorganic Chemicals · STDN

ipo amended New York Stock Exchange S-1

Standard Nuclear, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: S-1 on 2026-06-18. Current deal snapshot: exchange New York Stock Exchange.

Filing Timeline

SEC EDGAR
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
Class A · Exchange New York Stock Exchange · Ticker STDN · Flags dual_class · Underwriters BofA Securities, Goldman Sachs & Co. LLC, Barclays
Standard Nuclear, Inc. acquired USNC Assets for $32.9M to become a reactor-agnostic TRISO fuel manufacturer, developing modular production capabilities. Recent milestones include a DOE OTA for advanced fuel facilities, receiving HALEU feedstock, and a joint venture with Framatome. The company aims to supply TRISO fuel to Nano and advance nuclear technology deployment through government programs.
2026-06-18 · 0001213900-26-070215
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2026-06-02 · 0001213900-26-064221
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2026-05-05 · 0001213900-26-051869
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
2026-04-10 · 0001213900-26-042144
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2026-02-13 · 0001213900-26-016600
Comparable Deals

17 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 17 using nearest neighbors.
Showing top 8 by similarity.
+7.9%
Median day-1
53%
Above issue
-0.5%
Median week-1
-20.9%
Downside (p10)
Kardigan, Inc. KARD
2026-06-18 $400M Day 1: +37.5% Wk 1: +37.5%
same SIC grouprecent IPO
SL Science Holding Ltd SLBT
2026-06-15 - Day 1: -16.8% Wk 1: +44.8%
same SIC grouprecent IPO
Parabilis Medicines, Inc. PBLS
2026-06-10 $670M Day 1: +58.0% Wk 1: +30.2%
same SIC grouprecent IPO
Odyssey Therapeutics, Inc. ODTX
2026-05-08 $279M Day 1: -8.8% Wk 1: -3.8%
same SIC grouprecent IPO
Seaport Therapeutics, Inc. SPTX
2026-05-01 $255M Day 1: +10.2% Wk 1: -13.9%
same SIC grouprecent IPO
Hemab Therapeutics Holdings, Inc. COAG
2026-05-01 $302M Day 1: +88.9% Wk 1: +43.0%
same SIC grouprecent IPO
Avalyn Pharma Inc. AVLN
2026-04-30 $300M Day 1: +63.8% Wk 1: +53.9%
same SIC grouprecent IPO
First Tracks Biotherapeutics, Inc. TRAX
2026-04-20 - Day 1: -9.3% Wk 1: -11.5%
same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.